Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
new york top stories
2
×
paul matteis
2
×
abbvie
acorda therapeutics
ampyra
apokyn
apomorphine
biomarin
dalfampridine
duopa
gene therapy
hemophilia
inbrija
international society on thrombosis and haemostasis
maury raycroft
mylan
new york
parkinson's disease
pfizer
san francisco
san francisco blog main
san francisco top stories
sangamo therapeutics
spark therapeutics
stiel
stifel
sunovion pharmaceuticals
What
acorda
approved
close
cope
data
disease
drug
episodes
fda
forward
friday
gene
gets
heated
help
hemophilia
late
looms
market
meant
medical
medications
meeting
new
nod
parkinson’s
past
patients
pfizer
race
rival
sangamo
step
stop
therapy
treatment
weekend
working
Language
Current search:
" paul matteis "
×
" new york top stories "
×
@xconomy.com
4 years ago
With Data, Pfizer/Sangamo Step Forward in Hemophilia Gene Therapy Race
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
